1. United Kingdom Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Surgical Innovations Group plc

Surgical Innovations Group plc

LLSE:SUN
0.40
GBX
0.00
(0.00%)
513.05MMarket Cap
Mar 25Next Earn
Surgical Innovations Group plc
LSE:SUN
(London Stock Exchange)

Recent

price

0.40

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
GBP
0.02
0.02
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
- -
Revenue per Share
- -
- -
- -
- -
-0.02
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.03
0.03
0.03
0.03
0.01
0.01
0.01
0.02
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Book Value per Share
0.02
0.02
0.02
0.01
0.01
0.01
0.01
- -
0.01
0.01
0.01
- -
- -
- -
- -
- -
- -
Tangible Book Value per Share
376
393
402
405
431
485
488
638
783
790
835
937
933
933
933
895
933
Basic Weighted Avg Shares
7
8
8
7
4
5
6
9
11
11
6
9
11
12
12
12
- -
Sales/Revenue/Turnover
27.59
23.24
17.32
3.32
-79.9
-36.12
7.7
6.87
3.16
-0.02
-37.43
-2.82
0.64
-4.89
-5.34
-7.57
- -
Operating Margin (%)
1
1
1
1
1
1
1
2
2
4
2
1
1
1
2
1
- -
Depreciation Expense
2
2
1
- -
-9
-2
1
- -
1
-3
-3
- -
- -
-1
-2
-1
- -
Net Income, GAAP
- -
- -
44.36
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
25.38
22.86
8.98
1.71
-234.72
-37.18
11.76
5.58
6.61
-24.4
-51.76
-5
2.33
-4.24
-16.27
-7.71
- -
Profit Margin (%)
5
4
5
3
5
4
3
4
5
4
6
4
4
3
2
2
2
Working Capital
1
1
1
1
4
3
- -
2
2
2
3
1
2
1
1
- -
1
LT Debt
11
13
14
13
6
4
6
14
14
12
11
11
11
10
9
8
9
Total Equity
- -
- -
4.45
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
4.46
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
18.6
14.98
5.24
0.95
-97.02
-40.46
14.66
5.03
5.18
-19.68
-28.14
-4.19
2.44
-4.75
-20.43
-11.06
- -
Return on Common Equity (%)

Capital Structure

GBP

•

in mil. unless spec.
Dec'23
Jun'24
Dec'24
ST Debt
1
1
1
LT Borrowings
1
- -
- -
LT Finance Leases
1
- -
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
933
933
933
Market Capitalization
6
4
5

Working Capital

GBP

•

in mil. unless spec.
Dec'23
Jun'24
Dec'24
Total Current Assets
6
6
5
Cash, Cash Equivalents & STI
1
- -
- -
Accounts Receivable, Net
2
2
2
Inventories
3
3
3
Total Current Liabilities
3
3
3
Payables & Accruals
- -
- -
- -
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

GBP

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.84%
-6.88%
-10.48%
Free Cash Flow
55.61%
-92.31%
-183.62%
Net Income, GAAP
-86.36%
-61.8%
-53.94%
Sales/Revenue/Turnover
10.82%
14.19%
-2.87%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
12
2024
- -
- -
12
2025
- -
- -
12

Semi-annual Earnings Per Share

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Semi-annual Dividends Per Share

GBP

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Surgical Innovations Group plc designs, develops, manufactures and sells medical devices for minimally invasive surgery and precision engineering applications; its core offerings include the Resposable YelloPort+ and YelloPortElite laparoscopic port access systems, Logi range of laparoscopic instruments, Logic reusable instruments, PretzelFlex organ and tissue retractor, LogiTube gastric calibration tubing for bariatric procedures, and Aspen portfolio products, alongside original equipment manufacturer services for bespoke medical devices and partnerships such as with DEAM for LaproFlex steerable instruments and CMR Surgical for hybrid ports. The company, founded in 1988 and headquartered in Leeds, United Kingdom, operates principally through its Surgical Innovations division with global distribution across Europe, the UK, USA, APAC and other regions, targeting hospitals and healthcare providers focused on sustainable keyhole surgery solutions that reduce costs by up to 58% per procedure and clinical waste by up to 85%. Recent developments encompass exclusive UK distribution agreements with Microline Surgical for five years and another partner for three years, robust 37% growth in SI branded products across key European markets in the first half of 2025 amid sustainability demand, introduction of the Aspen portfolio driving strong UK sales, ongoing cost-reduction initiatives delivering margin benefits from early 2026, and sustained investment in sales and R&D to support revenue expansion into 2026.